Treatment | Concentration (μg/g) | Fat content (%) ± SE at time (day) | Average ± SE | ||
---|---|---|---|---|---|
3 | 7 | 10 | |||
Control+ | 0.00 | 21.00 ± 0.58 | 20.25 ± 0.14 | 20.13 ± 0.07 | 20.46ab ± 0.27 |
Control− | 0.00 | 22.70 ± 0.06 | 22.62 ± 0.01 | 22.61 ± 0.01 | 22.65c ± 0.03 |
Ch | 1000 | 21.00 ± 0.58 | 19.85 ± 0.09 | 19.92 ± 0.04 | 20.26a ± 0.37 |
2500 | 24.20 ± 0.12 | 24.25 ± 0.09 | 24.32 ± 0.04 | 24.26d ± 0.04 | |
Ch-AgNP1 | 1000 | 22.50 ± 0.87 | 20.76 ± 0.14 | 20.58 ± 0.24 | 21.28b ± 0.61 |
2500 | 20.90 ± 0.17 | 20.39 ± 0.12 | 20.36 ± 0.14 | 20.55b ± 0.18 | |
Ch-AgNP2 | 1000 | 20.50 ± 0.64 | 20.47 ± 0.23 | 20.28 ± 0.15 | 20.41a ± 0.07 |
2500 | 20.50 ± 0.29 | 20.49 ± 0.30 | 20.46 ± 0.31 | 20.48b ± 0.01 | |
Ch-AgNP3 | 1000 | 21.00 ± 0.58 | 19.94 ± 0.04 | 19.97 ± 0.02 | 20.30a ± 0.35 |
2500 | 26.80 ± 0.46 | 25.83 ± 1.02 | 25.66 ± 0.89 | 26.09e ± 0.36 | |
Mean | 21.98b | 21.4a | 21.34a | Between treatment for 1000 = 0.59 | |
LSD0.05 | Between time = 0.310 | Between treatment for 2500 = 0.65 |